MCID: SPN041
MIFTS: 51

Spinal Cord Disease malady

Categories: Neuronal diseases, Bone diseases, Immune diseases

Aliases & Classifications for Spinal Cord Disease

Summaries for Spinal Cord Disease

MedlinePlus : 41 your spinal cord is a bundle of nerves that runs down the middle of your back. it carries signals back and forth between your body and your brain. it is protected by your vertebrae, which are the bone disks that make up your spine. if you have an accident that damages the vertebrae or other parts of the spine, this can also injure the spinal cord. other spinal cord problems include tumors infections such as meningitis and polio inflammatory diseases autoimmune diseases degenerative diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy symptoms vary but might include pain, numbness, loss of sensation and muscle weakness. these symptoms can occur around the spinal cord, and also in other areas such as your arms and legs. treatments often include medicines and surgery.

MalaCards based summary : Spinal Cord Disease, also known as spinal cord diseases, is related to syphilis and vascular myelopathy, and has symptoms including back pain, headache and hemiplegia. An important gene associated with Spinal Cord Disease is AQP4 (Aquaporin 4), and among its related pathways/superpathways are Spinal Cord Injury and Primary immunodeficiency. The drugs Propofol and Sevoflurane have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, bone and brain, and related phenotypes are hematopoietic system and nervous system

Wikipedia : 71 Myelopathy describes any neurologic deficit related to the spinal cord. When due to trauma, it is known... more...

Related Diseases for Spinal Cord Disease

Diseases related to Spinal Cord Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 118)
id Related Disease Score Top Affiliating Genes
1 syphilis 29.1 CD4 CD40LG
2 vascular myelopathy 12.3
3 htlv-1 associated myelopathy/tropical spastic paraparesis 12.1
4 myelopathy, htlv-1-associated 12.1
5 syphilitic myelopathy 12.1
6 retrovirus-associated myelopathy 12.0
7 tropical spastic paraparesis 11.7
8 spondylosis 11.4
9 human t-cell leukemia virus type 1 11.2
10 foix-alajouanine syndrome 11.1
11 tabes dorsalis 11.0
12 neuroschistosomiasis 11.0
13 ossification of the posterior longitudinal ligament of spine 11.0
14 central nervous system disease 10.7
15 tarlov cysts 10.7
16 sneddon syndrome 10.7
17 myelitis 10.7
18 glossopharyngeal nerve neoplasm 10.3 AQP4 AVPR2
19 childhood brainstem astrocytoma 10.3 AQP4 MBP
20 hyperostosis 10.3 AVPR2 MBP SERPINH1
21 paraurethral gland cancer 10.2 AQP4 SERPINH1
22 alcoholic pancreatitis 10.2 CD4 CD8A
23 orbital disease 10.2 CD4 CD8A
24 crest syndrome 10.2 AQP4 MBP
25 spinal polio 10.2 CD40LG MBP
26 ovarian disease 10.2 AQP4 CD8A MBP
27 scrotum melanoma 10.2 CD4 CD8A
28 cervix melanoma 10.2 CD4 CD8A
29 schwannoma of jugular foramen 10.2 ADAMTS1 COL6A1 MBP
30 coronin-1a deficiency 10.2 CD4 CD8A
31 prostate carcinoma in situ 10.2 CD4 CD40LG
32 mild pre-eclampsia 10.2 CD40LG CD8A
33 scrotum squamous cell carcinoma 10.2 CD4 CD8A
34 epidermolysis bullosa acquisita 10.2 AVPR2 COL6A1 HSF4
35 endocarditis 10.1 CD40LG HSF4
36 postcricoid region cancer 10.1 CD40LG CD8A
37 early yaws 10.1 CD40LG GDNF MBP
38 eczema herpeticum 10.1 CD4 CD8A
39 cysticercosis 10.1 CD4 CD40LG
40 atypical breast papilloma 10.1 CD4 CD40LG
41 angiolipoma 10.1 CD4 CD40LG
42 chronic duodenal ileus 10.1 CD4 CD40LG MBP
43 meningeal melanoma 10.1 ADAMTS1 COL6A1 TMTC1
44 alopecia-intellectual disability syndrome 10.1 MBP MOG
45 mumps 10.1 CD40LG ERVW-1
46 plasmacytic leukemia 10.1 CD4 CD8A
47 uterine ligament serous adenocarcinoma 10.1 AQP4 CD40LG COL6A1
48 colloid adenoma 10.0 CD4 CD40LG CD8A
49 retinal microaneurysm 10.0 CD4 CD40LG CD8A
50 infundibulocystic basal cell carcinoma 10.0 CD4 CD40LG CD8A

Comorbidity relations with Spinal Cord Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Decubitus Ulcer
Deficiency Anemia Hypertension, Essential
Osteoporosis Paraplegia
Prostate Cancer Spinal Stenosis

Graphical network of the top 20 diseases related to Spinal Cord Disease:



Diseases related to Spinal Cord Disease

Symptoms & Phenotypes for Spinal Cord Disease

UMLS symptoms related to Spinal Cord Disease:


back pain, headache, hemiplegia, myoclonus, pain, sciatica, seizures, syncope, tremor, chronic pain, hyperexplexia, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Spinal Cord Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.85 AQP4 AVPR2 CD4 CD40LG CD8A GDNF
2 nervous system MP:0003631 9.65 SERPINH1 SOD1 AQP4 CD4 CD40LG CD8A
3 renal/urinary system MP:0005367 9.17 ADAMTS1 AQP4 AVPR2 BTD CD40LG GDNF

Drugs & Therapeutics for Spinal Cord Disease

Drugs for Spinal Cord Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 772)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 1 2078-54-8 4943
2
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
3
Ziconotide Approved Phase 4 107452-89-1 447451
4
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
5
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
6
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3 148553-50-8 5486971
7
Benzocaine Approved Phase 4,Phase 2,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
8
Riluzole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 1744-22-5 5070
9
Mitoxantrone Approved, Investigational Phase 4 65271-80-9 4212
10
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
11
Memantine Approved, Investigational Phase 4,Phase 2,Phase 3 19982-08-2 4054
12
Amitriptyline Approved Phase 4 50-48-6 2160
13
Cyclobenzaprine Approved Phase 4 303-53-7 2895
14
Acetazolamide Approved, Vet_approved Phase 4,Phase 2 59-66-5 1986
15
Zoledronic acid Approved Phase 4,Phase 2,Phase 3,Phase 1 118072-93-8 68740
16
Oxybutynin Approved, Investigational Phase 4,Phase 3 5633-20-5 4634
17
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
18
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
19
Bupivacaine Approved, Investigational Phase 4,Phase 2 2180-92-9, 38396-39-3 2474
20
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 124-94-7 31307
21
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
22
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 83-43-2 6741
23
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 50-24-8 5755
24
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2 437-38-7 3345
25
Meloxicam Approved, Vet_approved Phase 4,Phase 3 71125-38-7 5281106 54677470
26
Norepinephrine Approved Phase 4,Phase 2 51-41-2 439260
27
Neostigmine Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 59-99-4 4456
28
Darifenacin Approved, Investigational Phase 4 133099-04-4 444031
29
Trospium Approved Phase 4,Phase 1 10405-02-4, 47608-32-2 5596 5284631
30
Tadalafil Approved, Investigational Phase 4,Phase 3 171596-29-5 110635
31 Piracetam Approved Phase 4,Phase 3,Phase 2 7491-74-9
32
Perphenazine Approved Phase 4 58-39-9 4748
33
Teriparatide Approved, Investigational Phase 4,Phase 2 52232-67-4 16133850
34
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
35
Oxcarbazepine Approved Phase 4 28721-07-5 34312
36
Goserelin Approved Phase 4 65807-02-5 47725 5311128
37
Interferon beta-1a Approved, Investigational Phase 4,Phase 2 145258-61-3 6438354
38
Mexiletine Approved Phase 4,Phase 2 31828-71-4 4178
39
Edetic Acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 60-00-4, 62-33-9 6049
40
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
41
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
42
Citalopram Approved Phase 4,Phase 3,Phase 1 59729-33-8 2771
43
Zinc Approved Phase 4,Phase 3,Phase 1,Phase 2 7440-66-6 32051 23994
44 Zinc sulfate Approved Phase 4 7733-02-0
45
Ramipril Approved Phase 4 87333-19-5 5362129
46
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
47
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
48
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2 27203-92-5 33741
49
Cytarabine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 147-94-4 6253
50
Midodrine Approved Phase 4,Phase 3,Phase 2 133163-28-7, 42794-76-3 4195

Interventional clinical trials:

(show top 50) (show all 2161)
id Name Status NCT ID Phase
1 Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy Unknown status NCT01052337 Phase 4
2 Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy Unknown status NCT01992562 Phase 4
3 Exoskeletons for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943669 Phase 4
4 Eyegaze Systems for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943656 Phase 4
5 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
6 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI Unknown status NCT02298660 Phase 4
7 Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain Unknown status NCT01479556 Phase 4
8 A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury Unknown status NCT00725790 Phase 4
9 Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis Unknown status NCT00560287 Phase 4
10 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4
11 Spinal Cord Stimulation (SCS) in Refractory Angina Unknown status NCT00121654 Phase 4
12 Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Unknown status NCT02021825 Phase 4
13 Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity Unknown status NCT01786005 Phase 4
14 Memantine for Post-Operative Pain Control Unknown status NCT01041313 Phase 4
15 Cyclobenzaprine Extended Release (ER) for Fibromyalgia Unknown status NCT01041495 Phase 4
16 Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty Unknown status NCT01616342 Phase 4
17 Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery Unknown status NCT01889498 Phase 4
18 Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients Unknown status NCT00912938 Phase 4
19 Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele Unknown status NCT00175123 Phase 4
20 The Effect of Ketamine Infusion on Lumbar Surgery Unknown status NCT02154438 Phase 4
21 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Completed NCT00629642 Phase 4
22 Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy Completed NCT00285337 Phase 4
23 Surgical Treatment of Cervical Spondylotic Myelopathy Completed NCT00565734 Phase 4
24 Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level Completed NCT00554528 Phase 4
25 Pregabalin and Radicular Pain Study (PARPS) Completed NCT01061697 Phase 4
26 Project to Improve Symptoms and Mood in People With Spinal Cord Injury Completed NCT00592384 Phase 4
27 Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage Completed NCT00745095 Phase 4
28 A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) Completed NCT00304291 Phase 4
29 Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression Completed NCT00634426 Phase 4
30 Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity Completed NCT00800462 Phase 4
31 Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels Completed NCT01896037 Phase 4
32 Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males Completed NCT01067391 Phase 4
33 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia Completed NCT00507546 Phase 4
34 Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury Completed NCT00252954 Phase 4
35 Chronic Pain in Spinal Cord Injury Completed NCT00006428 Phase 4
36 Assess Efficacy in Subjects With Traumatic Spinal Cord Injury Completed NCT00667966 Phase 4
37 Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients Completed NCT01579500 Phase 4
38 Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury. Completed NCT00320281 Phase 4
39 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury Completed NCT00286520 Phase 4
40 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) Completed NCT00826228 Phase 4
41 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction Completed NCT00654082 Phase 4
42 Symptom Based Treatment of Neuropathic Pain Completed NCT02180880 Phase 4
43 Zoledronic Acid Administration in Acute Spinal Cord Injury Completed NCT02042872 Phase 4
44 Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy Completed NCT00851461 Phase 4
45 Myobloc Atrophy Study Completed NCT02052024 Phase 4
46 Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine Completed NCT02643368 Phase 4
47 Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules Completed NCT02412514 Phase 4
48 Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Completed NCT00179478 Phase 4
49 Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS) Completed NCT00613899 Phase 4
50 CARE Canadian ALS Riluzole Evaluation Completed NCT00542412 Phase 4

Search NIH Clinical Center for Spinal Cord Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: spinal cord diseases

Genetic Tests for Spinal Cord Disease

Genetic tests related to Spinal Cord Disease:

id Genetic test Affiliating Genes
1 Myelopathy 29

Anatomical Context for Spinal Cord Disease

MalaCards organs/tissues related to Spinal Cord Disease:

39
Spinal Cord, Bone, Brain, Bone Marrow, T Cells, Testes

Publications for Spinal Cord Disease

Articles related to Spinal Cord Disease:

(show top 50) (show all 76)
id Title Authors Year
1
Primary central nervous system lymphoma of T-cell origin: an unusual cause of spinal cord disease. ( 27878765 )
2016
2
Prevalence, clinical presentation, prognosis, and outcome of 17 dogs with spinal shock and acute thoracolumbar spinal cord disease. ( 26676985 )
2016
3
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. ( 25542977 )
2015
4
Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. ( 25224602 )
2014
5
Autonomic rectal dysfunction in patients with multiple sclerosis and bowel symptoms is secondary to spinal cord disease. ( 24608309 )
2014
6
STIR muscle hyperintensity in the cervical muscles associated with inflammatory spinal cord disease of unknown origin. ( 23458643 )
2013
7
Positron emission tomography in spinal cord disease. ( 24182699 )
2013
8
Depression and pain among inpatients with spinal cord injury and spinal cord disease: differences in symptoms and neurological function. ( 23072715 )
2013
9
Spinal cord disease in patients with cancer. ( 22810129 )
2012
10
Stress, internal resources and functioning in a person with spinal cord disease. ( 22430577 )
2012
11
Low serum vitamin D levels and recurrent inflammatory spinal cord disease. ( 22083799 )
2012
12
Anorectal function and the effect of biofeedback therapy in ambulatory spinal cord disease patients having constipation. ( 20602567 )
2010
13
Clinical and magnetic resonance imaging findings in 92 cats with clinical signs of spinal cord disease. ( 18602328 )
2009
14
Characterization of spatiotemporal gait characteristics in clinically normal dogs and dogs with spinal cord disease. ( 19951114 )
2009
15
Surgical management of pressure ulcers during inpatient neurologic rehabilitation: outcomes for patients with spinal cord disease. ( 19569459 )
2009
16
Rehabilitation outcomes after infection-related spinal cord disease: a retrospective analysis. ( 18356619 )
2008
17
Profound biotinidase deficiency in a child with predominantly spinal cord disease. ( 18645204 )
2008
18
Signs of spinal cord disease in two heifers caused by Listeria monocytogenes. ( 14758832 )
2004
19
From the electrodiagnosis lab...H-reflexes in hand muscles after cervical spinal cord disease. ( 14598812 )
2003
20
Spinal cord disease in West Nile virus infection. ( 12571269 )
2003
21
Spinal cord disease in West Nile virus infection. ( 12575663 )
2003
22
Correlation between severity of clinical signs and motor evoked potentials after transcranial magnetic stimulation in large-breed dogs with cervical spinal cord disease. ( 12420825 )
2002
23
The use of magnetic motor evoked potentials in horses with cervical spinal cord disease. ( 11902758 )
2002
24
Electrophysiological evaluation of root and spinal cord disease. ( 12524565 )
2002
25
Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. ( 12121731 )
2002
26
Spinal cord disease due to melioidosis. ( 10450444 )
1999
27
Intrathecal baclofen therapy for spinal origin spasticity: spinal cord injury, spinal cord disease, and multiple sclerosis. ( 22151114 )
1999
28
The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. ( 9494998 )
1998
29
Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. ( 9494997 )
1998
30
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. ( 8649545 )
1996
31
Vertebrospinal angiography in the evaluation of vertebral and spinal cord disease. ( 8873094 )
1996
32
Spontaneous ejaculation secondary to spinal cord disease. ( 8164008 )
1994
33
Spinal cord disease due to vacuolar myelopathy in AIDS. ( 8039791 )
1994
34
Somatosensory potentials in dogs with naturally acquired thoracolumbar spinal cord disease. ( 8291776 )
1993
35
Repair and regeneration: experimental aspects of spinal cord disease. ( 1515695 )
1992
36
Congenital, hereditary and developmental spinal cord disease. ( 1325226 )
1992
37
The diagnostic impact of magnetic resonance imaging on the evaluation of suspected spinal cord disease. ( 1441553 )
1992
38
Management of bowel dysfunction in children with spinal cord disease or injury by means of the enema continence catheter. ( 1735813 )
1992
39
Disturbed sexual function in patients with spinal cord disease. ( 1921957 )
1991
40
Medical complications of spinal cord disease. ( 1921958 )
1991
41
Disorders of bladder function in spinal cord disease. ( 1921955 )
1991
42
Rehabilitation of patients with spinal cord disease. ( 1921954 )
1991
43
Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. ( 2234312 )
1990
44
Cervical spine: MR imaging with a partial flip angle, gradient-refocused pulse sequence. Part II. Spinal cord disease. ( 3336723 )
1988
45
Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. ( 2468107 )
1988
46
Medical management of spinal cord disease. ( 3113696 )
1987
47
Spinal-evoked potentials in dogs with acute compressive thoracolumbar spinal cord disease. ( 3674565 )
1987
48
Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. ( 3748677 )
1986
49
The value of paraxial slices in MR-imaging of spinal cord disease. ( 3762914 )
1986
50
Magnetic resonance imaging of spinal cord disease of childhood. ( 3737301 )
1986

Variations for Spinal Cord Disease

Expression for Spinal Cord Disease

Search GEO for disease gene expression data for Spinal Cord Disease.

Pathways for Spinal Cord Disease

Pathways related to Spinal Cord Disease according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.21 AQP4 GDNF MBP
2 10.37 CD4 CD40LG CD8A

GO Terms for Spinal Cord Disease

Cellular components related to Spinal Cord Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 T cell receptor complex GO:0042101 8.96 CD4 CD8A
2 external side of plasma membrane GO:0009897 8.92 AQP4 CD4 CD40LG CD8A

Biological processes related to Spinal Cord Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 central nervous system development GO:0007417 9.13 BTD MBP MOG
2 positive regulation of calcium-mediated signaling GO:0050850 8.62 CD4 CD8A

Sources for Spinal Cord Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....